Avery Dennison Medical Solutions and Proteus Biomedical Launch Partnership

Avery Dennison Medical Solutions, a division of Avery Dennison Corporation

in cooperation with Proteus Biomedical today announced a partnership focusing on patch-based wearable sensors for consumer, home health care and remote medical applications. Financial terms were not disclosed. Wearable Sensor for Personal Monitoring and Mobile Health Proteus has developed a U.S. FDA 510K cleared and European Union CE Mark-certified personal monitoring device for continuous physiologic sensing and monitoring. Proteus and Avery Dennison Medical Solutions have joined forces to reduce cost, enhance wearability and commercialize this advanced platform. Proteus' personal monitoring technology incorporates multiple sensors to monitor important physiologic parameters of interest to consumers and clinicians, including heart rate, physical activity and sleep patterns. Avery Dennison Medical Solutions is providing adhesive and material technologies and developing the manufacturing platform to mass produce the wearable sensors for the companies' respective customers. “The partnership with Proteus is a key component of our strategy to become a leader in the emerging areas of consumer and remote patient monitoring,” said Howard Kelly, vice president and general manager, Avery Dennison Medical Solutions. “Proteus' personal monitoring technology, combined with our expertise in skin-friendly adhesives and advanced manufacturing capabilities, provide a platform for innovative products that can help improve people's quality of life and reduce healthcare costs.”